Glutathione S transferase T1 gene polymorphism and its promoter methylation are associated with breast cancer susceptibility in Egyptian women. (19th March 2021)

• Record Type: Journal Article
• Authors: Raafat, Nermin; Ismail, Khadiga; Hawsawi, Nahed M.; Saber, Taisir; Elsawy, Wael H.; Abdulmutaleb, Tariq; Raafat, Ahmed; Gharib, Amal F.
• Is Part Of: Biotechnology and applied biochemistry. Volume 69:Number 2(2022)
• Page Start: 526
• Page End: 533
• Publication Date: 2021-03-19
• Subjects: cancer breast -- DNA methylation -- gene polymorphism -- GST; Biotechnology -- Periodicals; Biochemical engineering -- Periodicals; Biochemistry -- Periodicals; Biochemistry -- Periodicals; Genetic Techniques -- Periodicals; Microbiological Techniques -- Periodicals; 660.6
• DOI: 10.1002/bab.2129
• Languages: English
• ISSNs: 0885-4513

Abstract

Abstract: Background: Breast cancer (BC) is one of the leading causes of cancer mortality in women. Glutathione S‐transferase ( GSTT1 ) is involved in activation of detoxification reactions and catalysis of chemicals conjugation with glutathione. GSTT1 genotype is a limiting factor for some environmental diseases. Epigenetic changes have an essential role in BC through inappropriate interaction between genomic and environmental risk factors. Aim: This study was directed to explore the association of BC risk with GSTT1 genetic variations and its methylation status in Egyptian women. Design and Methods: This study included 100 healthy women as the control group and 100 patients were clinically and histologically diagnosed with breast cancer. All blood samples were used for genomic DNA extraction. GSTT1 genotyping was accomplished by multiplex PCR and methylation‐specific PCR was used to analyze the GSTT1 promoter methylation status. Results: Breast cancer patients showed significant incidence of null GSTT1 in relation to controls ( p = 0.004). GSTT1 gene promoter methylation status showed significant difference between hypermethylated and unmethylated patients when compared with healthy subjects ( p = 0.005). GSTT1 promoter methylation status was not significantly associated with null genotype. There was no significant association between GSTT1 ‐null genotypes and BC stage in cases with or without family history, but for promotor methylation, there was significant association with stage III and IV breast cancer disease. Conclusion: GSTT1 null genetic variant and promoter hypermethylation in the GSTT region of the gene may be considered as critical risk factors for BC in Egyptian women. Abstract : Graphical Abstract